COLLAGEN BOOST MOISTURIZER SPF 25- octinoxate, octocrylene, octisalate, avobenzone, homosalate cream
Peer Pharma Ltd.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
ArganiCare Collagen Boost SPF 25
Octinoxate 7%
Octocrylene 5%
Octisalate 5%
Avobenzone 3%
Homosalate 2%
Keep out of reach of children.
Provides SPF 25 protection
To Use: Smooth onto face.
For Sunscreen Use: Apply liberally 15 minutes before sun exposure. Reapply at least every 2 hours.
Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10 a.m. - 2 p.m. Wear long-sleeve shirts, pants, hats, and sunglasses.
COLLAGEN BOOST MOISTURIZER SPF 25
octinoxate, octocrylene, octisalate, avobenzone, homosalate cream |
Product Information |
Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 69435-1802 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) | OCTOCRYLENE | 5 g in 100 mL |
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) | OCTISALATE | 5 g in 100 mL |
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) | AVOBENZONE | 3 g in 100 mL |
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) | HOMOSALATE | 2 g in 100 mL |
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) | OCTINOXATE | 7 g in 100 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 69435-1802-1 | 50 mL in 1 CONTAINER; Type 0: Not a Combination Product | 05/09/2018 | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part352 | 05/09/2018 | 08/14/2019 |
|
Labeler - Peer Pharma Ltd.
(514678390)
|
Registrant - Peer Pharma Ltd. (514678390) |
Establishment |
Name | Address | ID/FEI | Business Operations |
Peer Pharma Ltd. | | 514678390 | manufacture(69435-1802) , label(69435-1802) |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.